EXELIXIS, INC. — Director's Dealing 2023

Mar 2, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2023-02-27

Reporting Person: Aftab Dana (CSO/EVP Disc & Trans Research)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-02-27	Common Stock	M	10	$14.74	Acquired	351482	Direct
2023-02-27	Common Stock	S	10	$17.50	Disposed	351472	Direct
2023-02-28	Common Stock	M	82490	$14.74	Acquired	433962	Direct
2023-02-28	Common Stock	S	82490	$17.50	Disposed	351472	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-02-27	Option (right to buy)	$14.74	M	10	Disposed	2023-09-21	Common Stock (10.0)	Direct
2023-02-28	Option (right to buy)	$14.74	M	82490	Disposed	2023-09-21	Common Stock (82490.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5835	Indirect

Footnotes

F1: Includes 210,090 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.

F2: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $17.50 to $17.51. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.

F3: Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of February 27, 2023.